The TUDOR domain of SMN is an H3K79


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
06 2023
Historique:
received: 05 10 2022
revised: 28 02 2023
accepted: 01 03 2023
entrez: 7 3 2023
pubmed: 8 3 2023
medline: 10 3 2023
Statut: epublish

Résumé

Spinal muscular atrophy is the leading genetic cause of infant mortality and results from depleted levels of functional survival of motor neuron (SMN) protein by either deletion or mutation of the

Identifiants

pubmed: 36882285
pii: 6/6/e202201752
doi: 10.26508/lsa.202201752
pmc: PMC9993015
pii:
doi:

Substances chimiques

Arginine 94ZLA3W45F
Lysine K3Z4F929H6
RNA Polymerase II EC 2.7.7.-
Transcription Factors 0
Survival of Motor Neuron 1 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : MOP 123381
Pays : Canada

Informations de copyright

© 2023 Binda et al.

Références

Genes Dev. 2014 Mar 15;28(6):622-36
pubmed: 24589551
PLoS One. 2011;6(6):e18919
pubmed: 21720545
Biochim Biophys Acta. 2014 Aug;1839(8):702-10
pubmed: 24583552
Nat Commun. 2017 Dec 12;8(1):2057
pubmed: 29234025
Biochemistry. 2020 Apr 14;59(14):1391-1397
pubmed: 32227847
Hum Mol Genet. 2000 Jan 22;9(2):259-65
pubmed: 10607836
Cell. 2007 Mar 9;128(5):1003-12
pubmed: 17350582
Neuron. 2019 Apr 17;102(2):294-320
pubmed: 30998900
Nature. 1997 Sep 18;389(6648):251-60
pubmed: 9305837
Nucleic Acids Res. 2011 Nov;39(21):9061-71
pubmed: 21813457
Mol Cell. 2013 Jun 6;50(5):613-23
pubmed: 23746349
J Cell Biol. 2002 Dec 23;159(6):957-69
pubmed: 12486110
Nat Struct Mol Biol. 2019 Oct;26(10):880-889
pubmed: 31582846
Mol Cell. 2016 Aug 4;63(3):470-84
pubmed: 27477906
PLoS One. 2010 Nov 02;5(11):e13559
pubmed: 21072162
J Cell Sci. 2013 Aug 15;126(Pt 16):3664-77
pubmed: 23750013
Nucleic Acids Res. 2019 Jan 10;47(1):168-183
pubmed: 30329130
Front Cell Dev Biol. 2021 Sep 16;9:729338
pubmed: 34604228
Elife. 2015 Aug 12;4:
pubmed: 26267306
Biomolecules. 2018 Feb 27;8(1):
pubmed: 29495487
Dev Cell. 2002 Sep;3(3):329-37
pubmed: 12361597
Brain Res. 2018 Aug 15;1693(Pt A):92-97
pubmed: 29462610
Nat Struct Mol Biol. 2011 Nov 20;18(12):1414-20
pubmed: 22101937
Cell. 2006 Dec 29;127(7):1361-73
pubmed: 17190600
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19266-71
pubmed: 20974918
Cell. 1995 Jan 13;80(1):155-65
pubmed: 7813012
J Biol Chem. 2020 Dec 4;295(49):16877-16887
pubmed: 32994220
Methods Enzymol. 2004;375:23-44
pubmed: 14870657
BMC Struct Biol. 2014 Dec 12;14:25
pubmed: 25494638
Biochemistry. 2016 Mar 22;55(11):1631-4
pubmed: 26562627
Epigenetics Chromatin. 2020 Jan 24;13(1):3
pubmed: 31980037
Epigenetics. 2013 Feb;8(2):177-83
pubmed: 23324626
Proc Natl Acad Sci U S A. 1964 May;51:786-94
pubmed: 14172992
Curr Biol. 2002 Jun 25;12(12):1052-8
pubmed: 12123582
Eur J Cell Biol. 2014 Mar;93(3):106-17
pubmed: 24602413
PLoS Genet. 2008 Sep 12;4(9):e1000190
pubmed: 18787701
J Biol Chem. 2016 Aug 26;291(35):18326-41
pubmed: 27281824
Molecules. 2018 Oct 12;23(10):
pubmed: 30322003
Genome Res. 2009 Oct;19(10):1732-41
pubmed: 19687145
Life Sci Alliance. 2022 Nov 14;6(1):
pubmed: 36375840
Cell. 2007 May 18;129(4):823-37
pubmed: 17512414
PLoS One. 2012;7(2):e30375
pubmed: 22363433
Cell. 2014 May 8;157(4):869-81
pubmed: 24813610
Br J Cancer. 2018 Mar 6;118(5):713-726
pubmed: 29381681
Mol Cell. 2009 Jan 30;33(2):248-56
pubmed: 19187765
Sci Rep. 2015 Jul 24;5:12485
pubmed: 26206755
Nature. 2004 Nov 18;432(7015):406-11
pubmed: 15525939
Nat Struct Mol Biol. 2008 Oct;15(10):1122-4
pubmed: 18794842
Annu Rev Cell Dev Biol. 2000;16:273-300
pubmed: 11031238
FEBS Lett. 2013 Mar 1;587(5):516-21
pubmed: 23353998
Nature. 2016 Jan 7;529(7584):48-53
pubmed: 26700805
Nat Struct Mol Biol. 2012 Dec;19(12):1218-27
pubmed: 23211769
BMC Genomics. 2012 Mar 29;13:123
pubmed: 22455468

Auteurs

Olivier Binda (O)

Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France olivier.binda@mail.mcgill.ca patrick.lomonte@univ-lyon1.fr.
University of Ottawa, Faculty of Medicine, Department of Cellular and Molecular Medicine, Ontario, Canada.

Aimé Boris Kimenyi Ishimwe (AB)

Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France.

Maxime Galloy (M)

Université Laval Cancer Research Center, Université Laval, Québec, Canada; Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, Canada; and Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, Canada.

Karine Jacquet (K)

Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France.

Armelle Corpet (A)

Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France.

Amélie Fradet-Turcotte (A)

Université Laval Cancer Research Center, Université Laval, Québec, Canada; Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, Canada; and Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Québec, Canada.

Jocelyn Côté (J)

University of Ottawa, Faculty of Medicine, Department of Cellular and Molecular Medicine, Ontario, Canada.

Patrick Lomonte (P)

Université Claude Bernard Lyon 1, CNRS UMR 5261, INSERM U1315, LabEx DEV2CAN, Institut NeuroMyoGène-Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Team Chromatin Dynamics, Nuclear Domains, Virus, Lyon, France olivier.binda@mail.mcgill.ca patrick.lomonte@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH